Prostate Cancer–Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era

PURPOSE: The long-term risk of prostate cancer–specific mortality (PCSM) after radical prostatectomy is poorly defined for patients treated in the era of widespread prostate-specific antigen (PSA) screening. Models that predict the risk of PCSM are needed for patient counseling and clinical trial de...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Stephenson, Andrew J., Kattan, Michael W., Eastham, James A., Bianco, Fernando J., Yossepowitch, Ofer, Vickers, Andrew J., Klein, Eric A., Wood, David P., Scardino, Peter T.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Clinical Oncology 2009
Onderwerpen:
Original Reports
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3651598/
https://ncbi.nlm.nih.gov/pubmed/19636023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.2501
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items